OncNGS consortium will challenge the market launching a pre-commercial procurement procedure, a competitive process enabling the buyers to compare the developments carried out by the contracted suppliers.
We are currently in Phase 0, a preparation stage. Define the needs by collecting feedback of the buyer’s group (during the OMC Open Market Consultation) and translate them into requirements and specifications to direct analysis and technical dialogue with the industry.
Concepts elaboration into the competitive solutions.
Minimum 4 designs will be selected.
Overall duration : 12 months – Execution : 6 months
Development of the well outlined and functioning prototypes.
Minimum 3 designs will be selected.
Overall duration : 15 months – Execution : 12 months
the functional and technical properties of the selected solutions will be evaluated in an operational environment.
Minimum of 2 pre-commercial devices will be deployed.
Overall duratiob : 18 months – Execution : 15 months
The oncNGS consortium groups several buyers in 5 EU countries to challenge the market to develop novel affordable solutions to provide the most advanced NGS tests for cancer patients. We wish to co-develop an EU innovative tender for liquid biopsy diagnostics based on complex NGS-driven DNA profiling within a pre-commercial procurement Horizon-2020 financed project.
As foreseen by the oncNGS Open Market Consultation, A[…]
The oncNGS PCP project launch its Open Market Consultation![…]
The prior information notice (PIN) has been published and[…]